Frederic Philippeau
Overview
Explore the profile of Frederic Philippeau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peter-Derex L, Philippeau F, Garnier P, Andre-Obadia N, Boulogne S, Catenoix H, et al.
Lancet Neurol
. 2022 Aug;
21(9):781-791.
PMID: 35963261
Background: The incidence of early seizures (occurring within 7 days of stroke onset) after intracerebral haemorrhage reaches 30% when subclinical seizures are diagnosed by continuous EEG. Early seizures might be...
2.
El Khoury C, Aboa-Eboule C, Fraticelli L, Claustre C, Bischoff M, Blanc-Lasserre K, et al.
J Am Coll Emerg Physicians Open
. 2022 Jan;
3(1):e12654.
PMID: 35079735
Objectives: To analyze the temporal trends in thrombolysis rates after implementation of a regional emergency network for acute ischemic stroke (AIS). Methods: We conducted a retrospective study based on a...
3.
Seners P, Ben Hassen W, Lapergue B, Arquizan C, Heldner M, Henon H, et al.
JAMA Neurol
. 2021 Jan;
78(3):321-328.
PMID: 33427887
Importance: The best reperfusion strategy in patients with acute minor stroke and large vessel occlusion (LVO) is unknown. Accurately predicting early neurological deterioration of presumed ischemic origin (ENDi) following intravenous...
4.
Laurencin C, Philippeau F, Blanc-Lasserre K, Vallet A, Cakmak S, Mechtouff L, et al.
Cerebrovasc Dis
. 2015 May;
40(1-2):3-9.
PMID: 25998791
Background: We evaluated the management, outcome and haemorrhagic risk in a cohort of ischaemic stroke patients with mild symptoms treated with intravenous tissue plasminogen activator (tPA) within the first 4.5...
5.
Nighoghossian N, Berthezene Y, Mechtouff L, Derex L, Cho T, Ritzenthaler T, et al.
Neurology
. 2015 May;
84(22):2216-23.
PMID: 25948727
Objectives: We examined whether IV administration of cyclosporine in combination with thrombolysis might reduce cerebral infarct size. Methods: Patients aged 18 to 85 years, presenting with an anterior-circulation stroke and...
6.
Lekoubou A, Philippeau F, Derex L, Olaru A, Gouttard M, Vieillart A, et al.
Neurol Res
. 2014 Mar;
36(7):687-94.
PMID: 24620962
Rationale: Post-intravenous recombinant tissue plasminogen activator (r-tPA) orolingual angioedema (PIROLA), including the life-threatening form, is an underappreciated complication of ischaemic stroke treatment. Aims: We present an audit report and a...
7.
Roux D, Philippeau F, Bhageerutty K, Vieillart A, Gouttard M, Boulliat J
Presse Med
. 2011 Mar;
40(6):668-70.
PMID: 21419592
No abstract available.
8.
Demarquay G, Derex L, Nighoghossian N, Adeleine P, Philippeau F, Honnorat J, et al.
Cerebrovasc Dis
. 2005 Jan;
19(2):65-8.
PMID: 15644623
Background: Many patients may be mentally incompetent or physically unable to give informed consent at the acute stage of stroke. Accordingly, we aimed to investigate the modalities of informed consent...
9.
Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezene Y, Philippeau F, et al.
J Neurol Sci
. 2004 Oct;
225(1-2):3-9.
PMID: 15465079
We hypothesized that pretreatment magnetic resonance imaging (MRI) parameters might predict clinical outcome, recanalization and final infarct size in acute ischemic stroke patients treated by intravenous recombinant tissue plasminogen activator...
10.
Derex L, Nighoghossian N, Hermier M, Pialat J, Wiart M, Philippeau F, et al.
Cerebrovasc Dis
. 2004 Jul;
18(3):232-5.
PMID: 15273440
Unlabelled: The significance of early ischemic changes (EICs) on CT remains controversial. MRI may provide relevant information in patients with EICs. Methods: EICs were assessed in patients with acute ischemic...